Retinal Hyperspectral Imaging in Neurodegenerative Diseases | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Retinal Hyperspectral Imaging in Neurodegenerative Diseases	Alzheimer disease, Arterial Occlusive Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Frontotemporal Lobar Degeneration, Hemic and Lymphatic Diseases, Leukoencephalopathies, Lewy body dementia, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Niemann-Pick disease, Nutritional and Metabolic Diseases, Parkinson disease, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, frontotemporal dementia, hereditary disease, histiocytosis, inborn errors of metabolism, intracranial arterial disease, intracranial arteriosclerosis, lymphatic system disorder, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, non-Langerhans cell histiocytosis, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, sphingolipidosis, synucleinopathy, tauopathy, vascular dementia, vascular disorder	Recruiting	Not applicable	2026-04-22		NCT07545473

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Center for Eye Research Australia	7

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Centre for Eye Research Australia	Melbourne	Australia	2